BG108496A - Mycoplasma bovis vaccine and methods of reducing pneumonia in animals - Google Patents

Mycoplasma bovis vaccine and methods of reducing pneumonia in animals

Info

Publication number
BG108496A
BG108496A BG108496A BG10849603A BG108496A BG 108496 A BG108496 A BG 108496A BG 108496 A BG108496 A BG 108496A BG 10849603 A BG10849603 A BG 10849603A BG 108496 A BG108496 A BG 108496A
Authority
BG
Bulgaria
Prior art keywords
mycoplasma bovis
vaccine
methods
animals
vaccines
Prior art date
Application number
BG108496A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robin Keich
David MCGAVIN
Robert YANCEY
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG108496A publication Critical patent/BG108496A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG108496A 2001-07-02 2003-12-22 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals BG108496A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
BG108496A true BG108496A (en) 2005-02-28

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108496A BG108496A (en) 2001-07-02 2003-12-22 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals

Country Status (31)

Country Link
US (1) US20030147914A1 (pt)
EP (1) EP1401488A1 (pt)
JP (1) JP2004536106A (pt)
KR (1) KR20040030783A (pt)
CN (1) CN1522152A (pt)
AP (1) AP2002002568A0 (pt)
AR (1) AR036125A1 (pt)
BG (1) BG108496A (pt)
BR (1) BR0210798A (pt)
CA (1) CA2452580A1 (pt)
CZ (1) CZ20033465A3 (pt)
EA (1) EA200301324A1 (pt)
GT (1) GT200200139A (pt)
HN (1) HN2002000162A (pt)
HR (1) HRP20031078A2 (pt)
HU (1) HUP0501188A2 (pt)
IL (1) IL159516A0 (pt)
IS (1) IS7078A (pt)
MA (1) MA27048A1 (pt)
MX (1) MXPA03011815A (pt)
NO (1) NO20035767L (pt)
OA (1) OA12640A (pt)
PA (1) PA8549801A1 (pt)
PE (1) PE20030239A1 (pt)
PL (1) PL373891A1 (pt)
SK (1) SK15802003A3 (pt)
TN (1) TNSN03154A1 (pt)
UY (1) UY27365A1 (pt)
WO (1) WO2003004052A1 (pt)
YU (1) YU102103A (pt)
ZA (1) ZA200309747B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
ES2535977T3 (es) 2006-09-11 2015-05-19 Zoetis P Llc Bacterinas tratadas térmicamente y vacunas en emulsión preparadas a partir de tales bacterinas tratadas térmicamente
UY31437A1 (es) * 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
CA2729080C (en) * 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
AU2009309041B2 (en) * 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2010140377A1 (ja) 2009-06-04 2010-12-09 独立行政法人産業技術総合研究所 マイコプラズマ感染症用ワクチン
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
CN115141772A (zh) 2015-08-14 2022-10-04 硕腾服务有限责任公司 牛支原体组合物
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP1229929A2 (en) * 1999-11-08 2002-08-14 Biomune VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
IS7078A (is) 2003-12-15
MXPA03011815A (es) 2004-04-02
OA12640A (en) 2006-06-15
PL373891A1 (en) 2005-09-19
CA2452580A1 (en) 2003-01-16
MA27048A1 (fr) 2004-12-20
CZ20033465A3 (cs) 2004-12-15
IL159516A0 (en) 2004-06-01
ZA200309747B (en) 2005-05-27
WO2003004052A1 (en) 2003-01-16
BR0210798A (pt) 2006-05-23
TNSN03154A1 (fr) 2005-12-23
PA8549801A1 (es) 2003-09-17
AP2002002568A0 (en) 2002-06-30
US20030147914A1 (en) 2003-08-07
CN1522152A (zh) 2004-08-18
AR036125A1 (es) 2004-08-11
UY27365A1 (es) 2003-04-30
HUP0501188A2 (en) 2006-05-29
EP1401488A1 (en) 2004-03-31
KR20040030783A (ko) 2004-04-09
EA200301324A1 (ru) 2004-12-30
JP2004536106A (ja) 2004-12-02
HRP20031078A2 (en) 2005-08-31
HN2002000162A (es) 2002-09-17
PE20030239A1 (es) 2003-03-21
GT200200139A (es) 2003-02-13
NO20035767L (no) 2004-01-30
YU102103A (sh) 2006-05-25
SK15802003A3 (sk) 2005-01-03

Similar Documents

Publication Publication Date Title
BG108496A (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
YU102203A (sh) Vakcinacija sa jednokratnom dozom mycoplasma hyopneumoniae
BRPI0010612B8 (pt) vacinas
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
ATE461709T1 (de) Choline-bindende proteine derivate aus pneumokoken als impfstoff
MY128159A (en) Methods and composition for oral vaccination
RU2005128790A (ru) Модифицированные живые вакцины, содержащие вирус бычьего герпеса типа 1 (bhv-1(ibr)) и/или вирус бычьей вирусной диареи (bvdv), для беременных и вскармливаемых особей скота
MXPA04001872A (es) Modelo de exposicion a micoplasma bovis, procedimiento para administrar m. bovis y procedimientos para inducir lesiones pulmonares neumonicas.
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
DE602005011041D1 (de) Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort
JP5865839B2 (ja) 粘膜アジュバント組成物
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo
Ibrahim et al. Use of Carbopol as an adjuvant in preparation of inactivated rabbit pasteurellosis vaccine
CY1116862T1 (el) Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae
FR2804026B1 (fr) Vaccination contre l'herpesvirose canine et vaccins
TH75687A (th) วัคซีนไวรัสโรคโลหิตจางในไก่จากเซลล์ไลน์
MY168662A (en) Attenuated bacteria for use in a vaccine
MY188912A (en) Attenuated bacteria for use in a vaccine
MY177159A (en) Attenuated bacteria for use in a vaccine
MY177164A (en) Attenuated bacteria for use in a vaccine
UA12940U (en) Associated inactivated concentrated velshipast vaccine against anaerobic enterotoxicemia and pasteurellosis of animals